Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth
of cancer.
PURPOSE: This phase I trial is studying the side effects and best dose of interferon alfa in
treating patients with stage IV solid tumors, lymphoma, or myeloma.